BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 24587184)

  • 1. Evaluation of the dosimetric feasibility of hippocampal sparing intensity-modulated radiotherapy in patients with locally advanced nasopharyngeal carcinoma.
    Han G; Liu D; Gan H; Denniston KA; Li S; Tan W; Hu D; Zhen W; Wang Z
    PLoS One; 2014; 9(2):e90007. PubMed ID: 24587184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
    Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
    Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Volumetric intensity-modulated arc therapy vs conventional intensity-modulated radiation therapy in nasopharyngeal carcinoma: a dosimetric study.
    White P; Chan KC; Cheng KW; Chan KY; Chau MC
    J Radiat Res; 2013 May; 54(3):532-45. PubMed ID: 23188186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced nasopharyngeal carcinoma radiotherapy with volumetric modulated arcs and the potential role of flattening filter-free beams.
    Zhuang M; Zhang T; Chen Z; Lin Z; Li D; Peng X; Qiu Q; Wu R
    Radiat Oncol; 2013 May; 8():120. PubMed ID: 23672519
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Qiu J; Lv B; Fu M; Wang X; Zheng X; Zhuo W
    Head Neck; 2017 Dec; 39(12):2519-2527. PubMed ID: 28963789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric evaluation of automatic and manual plans for early nasopharyngeal carcinoma to radiotherapy.
    Zhang Q; Peng Y; Song X; Yu H; Wang L; Zhang S
    Med Dosim; 2020 Spring; 45(1):e13-e20. PubMed ID: 31466735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A knowledge-based intensity-modulated radiation therapy treatment planning technique for locally advanced nasopharyngeal carcinoma radiotherapy.
    Bai P; Weng X; Quan K; Chen J; Dai Y; Xu Y; Lin F; Zhong J; Wu T; Chen C
    Radiat Oncol; 2020 Aug; 15(1):188. PubMed ID: 32746873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential for reduced radiation-induced toxicity using intensity-modulated arc therapy for whole-brain radiotherapy with hippocampal sparing.
    Pokhrel D; Sood S; Lominska C; Kumar P; Badkul R; Jiang H; Wang F
    J Appl Clin Med Phys; 2015 Sep; 16(5):131–141. PubMed ID: 26699321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of dose-volume histogram prediction for organ-at risk and planning target volume based on machine learning.
    Jiao SX; Wang ML; Chen LX; Liu XW
    Sci Rep; 2021 Feb; 11(1):3117. PubMed ID: 33542427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric comparison between jaw tracking and static jaw techniques in intensity-modulated radiotherapy.
    Feng Z; Wu H; Zhang Y; Zhang Y; Cheng J; Su X
    Radiat Oncol; 2015 Jan; 10():28. PubMed ID: 25623899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Volumetric modulated arc therapy for nasopharyngeal carcinoma: a dosimetric comparison with TomoTherapy and step-and-shoot IMRT.
    Lu SH; Cheng JC; Kuo SH; Lee JJ; Chen LH; Wu JK; Chen YH; Chen WY; Wen SY; Chong FC; Wu CJ; Wang CW
    Radiother Oncol; 2012 Sep; 104(3):324-30. PubMed ID: 22236614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determining appropriate timing of adaptive radiation therapy for nasopharyngeal carcinoma during intensity-modulated radiation therapy.
    Huang H; Lu H; Feng G; Jiang H; Chen J; Cheng J; Pang Q; Lu Z; Gu J; Peng L; Deng S; Mo Y; Wu D; Wei Y
    Radiat Oncol; 2015 Sep; 10():192. PubMed ID: 26377685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric comparison of intensity modulated radiotherapy and intensity modulated proton therapy in the treatment of recurrent nasopharyngeal carcinoma.
    Hung HM; Chan OCM; Mak CH; Hung WM; Ng WT; Lee MCH
    Med Dosim; 2022 Spring; 47(1):14-19. PubMed ID: 34470708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of hippocampus dose for patients undergoing intensity-modulated radiotherapy for nasopharyngeal carcinoma.
    Khodayari B; Michaud AL; Stanic S; Wooten OH; Dublin A; Purdy JA; Chen AM
    Br J Radiol; 2014 May; 87(1037):20130474. PubMed ID: 24620838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetric evaluation of four whole brain radiation therapy approaches with hippocampus and inner ear avoidance and simultaneous integrated boost for limited brain metastases.
    Jiang A; Sun W; Zhao F; Wu Z; Shang D; Yu Q; Wang S; Zhu J; Yang F; Yuan S
    Radiat Oncol; 2019 Mar; 14(1):46. PubMed ID: 30876444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric Evaluation of a Simple Planning Technique for Improving Intensity-Modulated Radiotherapy for Nasopharyngeal Cancer.
    Lu JY; Cheung ML; Li M; Huang BT; Xie WJ; Xie LX
    PLoS One; 2015; 10(7):e0129461. PubMed ID: 26132167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Volumetric-modulated arc therapy vs. c-IMRT in esophageal cancer: a treatment planning comparison.
    Yin L; Wu H; Gong J; Geng JH; Jiang F; Shi AH; Yu R; Li YH; Han SK; Xu B; Zhu GY
    World J Gastroenterol; 2012 Oct; 18(37):5266-75. PubMed ID: 23066322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tomotherapy as a neoadjuvant treatment for locally advanced esophageal cancer might increase bone marrow toxicity in comparison with intensity-modulated radiotherapy and volumetric-modulated arc therapy.
    Wang Y; Xiao Q; Zeng B; Ni Q; Liu X; Liu X; Tian L; Sheng C; Peng L; Wang H
    Med Dosim; 2020 Spring; 45(1):e6-e12. PubMed ID: 31176536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of the factors which affect the interpatient organ-at-risk dose sparing variation in IMRT plans.
    Yuan L; Ge Y; Lee WR; Yin FF; Kirkpatrick JP; Wu QJ
    Med Phys; 2012 Nov; 39(11):6868-78. PubMed ID: 23127079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A split-organ delineation approach for dose optimisation for intensity-modulated radiotherapy for advanced T-stage nasopharyngeal carcinoma.
    Chau RM; Leung SF; Kam MK; Cheung KY; Kwan WH; Yu KH; Chiu SK; Chan AT
    Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):134-41. PubMed ID: 18031999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.